ACE, MTHFR, Factor V Leiden, and APOE Polymorphisms in Patients With Vascular and Alzheimer’s Dementia

Stroke - Tập 29 Số 7 - Trang 1401-1404 - 1998
Joab Chapman1, Ningshan Wang1, T. A. Treves1, Amos D. Korczyn1, Natan M. Bornstein1
1From the Department of Physiology and Pharmacology (J.C., N.W., A.D.K.) and Department of Neurology (J.C., T.A.T., A.D.K., N.M.B.), Tel Aviv Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Israel.

Tóm tắt

Background and Purpose —There is a growing interest in the use of genetic markers in the differential diagnosis of dementia. In the current study we examined the usefulness of genetic risk factors for vascular disease as markers for vascular dementia (VD). Methods —The groups included 41 patients with VD, 49 patients with dementia of the Alzheimer’s type, and 40 age-matched control subjects without dementia. These patients were genotyped for vascular disease–associated polymorphisms in the genes coding for methylenetetrahydrofolate reductase (MTHFR), angiotensin-converting enzyme (ACE), factor V Leiden (FVL), and a common genetic risk factor for AD, apolipoprotein E ε4 (APOE ε4). Results —There was no significant association between ACE, MTHFR, and FVL genotypes with VD whether compared with subjects with AD or with control subjects. There was a higher frequency of APOE ε4 alleles in patients with AD (30%, P =0.016) and VD (26%, P =0.07) compared with control subjects (15%). Conclusions —VD is not associated with the genetic risk factors for vascular disease examined in this study, indicating that the pathogenesis of VD may differ from other vascular diseases.

Từ khóa


Tài liệu tham khảo

10.1136/bmj.312.7025.227

10.1212/WNL.43.2.250

10.1161/str.28.2.459

10.1016/S0193-953X(18)30305-8

10.1212/WNL.49.3.690

10.1161/str.27.1.30

Cambien F Poirier O Lecerf L Evans A Cambou JP Arveiler D Luc G Bard JM Bara L Ricard S et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992;359:641–644.

10.1161/str.26.8.1329

10.1161/str.27.3.435

10.1038/ng0595-111

10.1038/369064a0

10.1056/NEJM199412083312305

Catto A, Carter A, Grant PJ. Factor V Leiden mutation and completed stroke. Stroke.. 1996;27:573. Letter.

10.1172/JCI117423

Sharma P, Carter ND, Barley J, Brown MM. Molecular approach to assessing the genetic risk of cerebral infarction: deletion polymorphism in the gene encoding angiotensin 1-converting enzyme. J Hum Hypertens.. 1994;8:645–648.

10.1161/circ.93.9.1630

10.1056/NEJM198509193131201

Engbersen AM, Franken DG, Boers GH, Stevens EM, Trijbels FJ, Blom HJ. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet.. 1995;56:142–150.

Kluitmans L, van den Heuvel L, Boers G, Frosst P, Stevens E, van Oost B, den Heijer M, Tribels FJ, Rozen R, Blom H. Molecular genetic analysis in mild hyperhomocyteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a risk factor for cardiovascular disease. Am J Hum Genet.. 1996;58:35–41.

10.1056/NEJM199504063321403

10.1212/WNL.34.7.939

10.1172/JCI114844

10.1212/WNL.46.5.1484

10.1097/00004872-199304000-00003

10.1097/00002093-199601040-00003

10.1016/0140-6736(93)91728-5

10.1212/WNL.44.12.2420

10.1136/jnnp.57.11.1414

10.1001/jama.1997.03540340052032

Arai H Higuchi S Sasaki H. Apolipoprotein E genotyping and cerebrospinal fluid tau protein: implications for the clinical diagnosis of Alzheimer’s disease. Gerontology. 1997;43(suppl 1):2–10.

10.1111/j.1399-0004.1996.tb02712.x

Cacabelos R, Rodriguez B, Carrera C, Caamano J, Beyer K, Lao JI, Sellers MA. APOE-related frequency of cognitive and noncognitive symptoms in dementia. Methods Find Exp Clin Pharmacol.. 1996;18:693–706.

Pirttila T, Lehtimaki T, Rinne J, Mattila K, Frey H, Nikkari T. The frequency of apolipoprotein E4 allele is not increased in patients with probable vascular dementia. Acta Neurol Scand.. 1996;93:352–354.

10.1016/0197-4580(96)00023-1

10.1016/0304-3940(96)12373-9

Isoe K, Urakami K, Sato K, Takahashi K. Apolipoprotein E in patients with dementia of the Alzheimer type and vascular dementia. Acta Neurol Scand.. 1996;93:133–137.

10.1016/0304-3940(95)12190-0

Mahieux F, Couderc R, Moulignier A, Bailleul S, Podrabinek N, Laudet J. Isoform 4 of apolipoprotein E, and Alzheimer disease: specificity and clinical study. Rev Neurol (Paris).. 1995;151:231–239.

Grearing M Mirra SS Hedreen JC Sumi SM Hansen LA Heyman A. The Consortion to Establish a Registry for Alzheimer’s Disease (CERAD) X: neuropathology confirmation of the clinical diagnosis of Alzheimer’s disease. Neurology. 1995;45(3 pt 1):461–466.

Thông tin
Thông tin xuất bản

Stroke

Tập 29 Số 7

1401-1404

Thông tin tác giả